SEC Form 4 · accession 0000899243-15-008083
Invuity, Inc. · IVTY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric W Roberts
Director
Period of report
Jun 15, 2015
Accepted (ET)
Nov 12, 2015 · 7:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393020
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2015 | P | 20,833 | $12.00 | A | 64,145 | D | |
| Common StockF1,F2 | holding | — | — | — | 326,086 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The number of shares reported in Column 5 is the number of shares beneficially owned as of the date of this filing and takes into account transactions reported on Form 4 since the date of the transaction reported herein.
- F2The shares are held by Valence CDK SPV, L.P. ("Valence CDK"). Valence Life Sciences GP II, LLC ("Valence") is the General Partner of Valence CDK. The Reporting Person is a Managing Member of Valence and disclaims beneficial ownership of the shares held by Valence CDK, except to the extent of his pecuniary interest therein
Remarks
Exhibit 24 - Power of Attorney